Table 1 Clinical characteristics of the study population
Variable | RFFF (n = 69) | ALTF (n = 31) | FFF (n = 25) |
|---|---|---|---|
Sex(n) | |||
male | 46 (66.7%) | 16 (51.6%) | 8 (32.0%) |
female | 23 (33.3%) | 15 (48.4%) | 17 (68.0%) |
Age(years) | 65.0 (15.0) | 62.0 (22.0) | 56.0 (16.0) |
BMI(kg/m²) | 26.7 (6.8) | 24.2 (8.2) | 23.6 (5.2) |
ASA(n) | |||
1 + 2 | 42 (60.9%) | 17 (54.8%) | 13 (52.0%) |
3 + 4 | 27 (39.1%) | 14 (45.2%) | 12 (48.0%) |
Flap location(n) | |||
tongue | 15 (21.7%) | 2 (6.5%) | 0 (0.0%) |
floor of mouth | 18 (26.1%) | 4 (12.9%) | 0 (0.0%) |
mandible | 5 (7.2%) | 12 (38.7%) | 21 (84.0%) |
maxilla + hard palate | 10 (14.5%) | 5 (16.1%) | 3 (12.0%) |
cheek | 7 (10.1%) | 1 (3.2%) | 0 (0.0%) |
soft palate | 4 (5.8%) | 2 (6.5%) | 0 (0.0%) |
extraoral | 10 (14.5%) | 5 (16.1%) | 1 (4.0%) |
Arterial anastomosis recipient vessel(n) | |||
ECA | 4 (5.8%) | 1 (3.2%) | 4 (16.0%) |
FAA | 27 (39.1%) | 12 (38.7%) | 10 (40.0%) |
LIA | 2 (2.9%) | 2 (6.5%) | 3 (12.0%) |
STA | 36 (52.2%) | 16 (51.6%) | 8 (32.0%) |
Surgery duration(min) | 513.0 (150.0) | 528.0 (91.0) | 545.0 (93.0) |
Flap ischemia duration(min) | 108.0 (28.0) | 105.0 (37.0) | 120.0 (38.0) |
Diabetes(n) | |||
no | 60 (87.0%) | 21 (67.7%) | 22 (88.0%) |
yes | 9 (13.0%) | 10 (32.3%) | 3 (12.0%) |
Arterial hypertension(n) | |||
no | 42 (60.9%) | 18 (58.1%) | 18 (72.0%) |
yes | 27 (39.1%) | 13 (41.9%) | 7 (28.0%) |
Smoking status(n) | |||
no | 42 (60.9%) | 17 (54.8%) | 15 (60.0%) |
yes | 27 (39.1%) | 14 (45.2%) | 10 (40.0%) |
Prior neck dissection(n) | |||
no | 61 (88.4%) | 23 (74.2%) | 12 (48.0%) |
yes | 8 (11.6%) | 8 (25.8%) | 13 (52.0%) |
Prior neck irradiation(n) | |||
no | 66 (95.7%) | 28 (90.3%) | 19 (76.0%) |
yes | 3 (4.3%) | 3 (9.7%) | 6 (24.0%) |
Flap survival(n) | |||
no | 0 (0.0%) | 0 (0.0%) | 2 (8.0%) |
yes | 69 (100.0%) | 31 (100.0%) | 23 (92.0%) |
Flap revision(n) | |||
no | 66 (95.7%) | 30 (96.8%) | 21 (84.0%) |
yes | 3 (4.3%) | 1 (3.2%) | 4 (16.0%) |